INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value
$121.16+3.09 (+2.62%)
Close on Nov 13, 2026Market cap $26.58BP/E –Yield –
Insmed enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Insmed's enterprise value was $25.74B on Nov 11, 2026, against $43.03B a year earlier. Over the last 5 years it ranged from $2.29B to $43.03B, with a median of $10.52B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $25.74B | -28.2% |
| 2025 | Dec 31, 2025 | $35.86B | +203.0% |
| 2024 | Dec 31, 2024 | $11.83B | +146.8% |
| 2023 | Dec 29, 2023 | $4.79B | +77.3% |
| 2022 | Dec 30, 2022 | $2.70B | -7.9% |
| 2021 | Dec 31, 2021 | $2.94B | -6.9% |
| 2020 | Dec 31, 2020 | $3.15B | +63.4% |
| 2019 | Dec 31, 2019 | $1.93B | +155.2% |
| 2018 | Dec 31, 2018 | $755.65M | -62.4% |
| 2017 | Dec 29, 2017 | $2.01B | +208.2% |
| 2016 | Dec 30, 2016 | $652.81M | -21.9% |
| 2015 | Dec 31, 2015 | $836.03M | +34.8% |
| 2014 | Dec 31, 2014 | $619.98M | +14.4% |
| 2013 | Dec 31, 2013 | $542.17M | +354.0% |
| 2012 | Dec 31, 2012 | $119.43M | – |
| 2011 | Dec 30, 2011 | -$7.46M | -9402.1% |
| 2010 | Dec 31, 2010 | $80.18K | – |
See a number that looks wrong?